RxDoctor Payments Data

Alison Boyce

Pediatric Endocrinology · Washington, DCNPI 1326209388

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $6,010 of the $6,484 with a category attached, or 92.7%. Ultragenyx Pharmaceutical Inc. accounts for 95.1% of it on its own, with 1 other manufacturer making up the rest.

$6,484in general payments, 2019–2025

Across 3 payments — averaging $2161.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ultragenyx Pharmaceutical Inc.$6K
  • AstraZeneca$321
$634,140in research payments, 2019–2025

Across 5 payments — averaging $126,828 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$634K

What the payments were for

  • Travel & lodging$6,01093%
  • Food & beverage$4747%

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Ultragenyx Pharmaceutical Inc.2$6,163
AstraZeneca1$321

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,484 in reported general payments places this provider in the 55th percentile of 20 pediatric endocrinology providers in District of Columbia.

See all pediatric endocrinology providers in District of Columbia →

Other pediatric endocrinology in Washington

See the full list for District of Columbia →

Where these figures come from

Is this you, or does something look wrong? →